← Eichor
Study identifier: NCT07323043 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia Induction

Condition: General Anesthetic Drug Adverse Reaction  ·  Sponsor: The First People's Hospital of Lianyungang

PhaseNA
Planned participants190
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

In patients undergoing general anesthesia with planned tracheal intubation , a prospective, randomized, controlled study was conducted to record the occurrence of cough 2 minutes after injection of Sufentanil or Tegilerdine. The cough was graded based on the frequency and duration: Grade I, no cough; Grade II, a single mild cough; Grade III, multiple coughs with duration \<1 second; Grade IV, continuous coughing with a duration \>15 seconds.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaobao Zhang, Doctor  ·  18961322507  ·  hotdog100@163.coom

Always discuss trial participation with your own doctor first.

Locations (1)

The Affiliated Lianyungang Hospital of Xuzhou Medical UniversityLianyungang, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07323043